Welcome to SCN2A Australia
SCN2A INTERNATIONAL AWARENESS DAY - 2021
About SCN2A Australia
We are parents of children who have SCN2A. Although our children have all had varying journeys, they are affected by SCN2A a devastating genetic mutation that causes death and severe disability for many children. We are dedicated to helping to develop treatments for SCN2A and developmental and epileptic encephalopathies (DEEs) and helping those working on and affected by DEEs better understand the conditions and live better lives.
We work with families, researchers, clinicians and professional bodies to improve the lives of those who have SCN2A and their families.
Connect with us via Facebook to Twitter to join us in our mission and keep up with the latest updates.
We also produce a podcast and a series of webinars on SCN2A and genetic epilepsies.
SCN2A International Natural History Study
Help understand SCN2A by enrolling in this natural history study which is open to participants from any country.
Dr Emma Palmer discusses how to decipher your genetic reports – what should be included and what does it mean?
Support for SCN2A and genetic epilepsy families
Suzanne is passionate about supporting families with a rare epilepsy diagnosis. She presents her research and the resources she has developed.
Understanding clinical variability for variants in the same gene
Prof Lynette Sadleir discusses how variants in genes such as SCN2A can lead to different clinical presentations.
Disease burden in genetic epilepsies – five things to know
Genetic epilepsies and developmental and epileptic encephalopathies (DEEs) significant impact the quality of life of patients.
All our knowledge begins with the antisenses
Up to date summary of antisense oligonucleotides (ASOs) and their role in the treatment of genetic epilepsies.
Parent-reported sleep profile of children with early-life epilepsies
Sleep problems are very common in children with early-life epilepsy.
Precision medicine approaches for infantile-onset developmental and epileptic encephalopathies
In children presenting with DEEs, genetic diagnoses can be made in over 50% of cases and inform precision medicine approaches to treatment.